Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.56 USD
Change Today +0.0389 / 7.48%
Volume 113.9K
CYCC On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for cyclacel pharmaceuticals inc (CYCC)

Year over year, Cyclacel Pharmaceuticals, Inc. has seen their bottom line shrink from a loss of $10.2M USD to an even larger loss of $19.4M USD despite an increase in revenues from $1.1M USD to $1.7M USD. An increase in the percentage of sales devoted to cost of goods sold from 1,040.31% to 1,054.04% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues--0.11.11.7
TOTAL REVENUES--0.11.11.7
Cost of Goods Sold9.26.611.318.3
GROSS PROFIT-9.2-6.5-10.2-16.5
Selling General & Admin Expenses, Total6.58.67.85.9
OTHER OPERATING EXPENSES, TOTAL6.58.67.85.9
OPERATING INCOME-15.7-15.1-18.0-22.4
Interest and Investment Income0.00.00.00.0
NET INTEREST EXPENSE0.00.00.00.0
Currency Exchange Gains (Loss)-0.10.30.10.0
Other Non-Operating Income (Expenses)0.60.10.60.1
EBT, EXCLUDING UNUSUAL ITEMS-15.2-14.7-17.3-22.3
Gain (Loss) on Sale of Assets--0.15.5--
Other Unusual Items, Total---0.4-0.1-0.3
Legal Settlements--0.0----
Other Unusual Items---0.4-0.1-0.3
EBT, INCLUDING UNUSUAL ITEMS-15.2-15.1-11.9-22.6
Income Tax Expense-0.6-1.4-1.7-3.2
Earnings from Continuing Operations-14.6-13.8-10.2-19.4
EARNINGS FROM DISCOUNTINUED OPERATIONS-0.60.60.10.0
NET INCOME-15.2-13.2-10.2-19.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-16.0-13.9-19.5-19.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-15.3-14.5-19.5-19.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYCC:US $0.56 USD +0.0389

CYCC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CYCC.
View Industry Companies
 

Industry Analysis

CYCC

Industry Average

Valuation CYCC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.7x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYCLACEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.